Federal grants to Nuvox Pharma, L.L.C.
Nuvox Pharma, L.L.C. in Tucson, Arizona received $4.0 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cancer Detection and Diagnosis Research, with $1.7 million. In fiscal 2025 it was awarded $1.2 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.0 million
- Awards5
- Awarded in FY 2025$1.2 million
- Largest award$1.5 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $478,050 |
| FY 2022 | 2 | $1.2 million |
| FY 2023 | 2 | $793,937 |
| FY 2024 | 1 | $299,243 |
| FY 2025 | 2 | $1.2 million |
Programs that fund Nuvox Pharma, L.L.C.
| Program | Awards | Amount |
|---|---|---|
| Cancer Detection and Diagnosis Research | 2 | $1.7 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 2 | $1.4 million |
| Military Medical Research and Development | 1 | $900,418 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.1 million |
| Department of Defense | 1 | $900,418 |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Nanoparticle-based sensitizer for radiation therapy of glioblastoma | Cancer Detection and Diagnosis Research | September 1, 2021 | $1.5 million |
| Liquid biopsy in glioblastoma treated with chemoradiation and an oxygen therapeutic - hypothesis and specific aims outcomes for patients with glioblastoma (GBM), the most aggressive malignant brain tumor in adults, are driven by the genetic underpinning of the tumor, such as methylation status of me | Cancer Detection and Diagnosis Research | September 23, 2025 | $919,366 |
| Dodecafluoropentane emulsion (DDFPE), NANO2? As cerebroprotectant in ischemic stroke - abstract / project summary stroke affects more than 795,000 patients per year in the us and kills approximately 40,000. Long-term medical care expense for stroke in the us, costs over $34B per year. Large vessel o | Extramural Research Programs in the Neurosciences and Neurological Disorders | April 7, 2023 | $900,552 |
| NANO2 enhances immunotherapy in triple negative breast cancers. | Military Medical Research and Development | July 26, 2022 | $900,418 |
| NANO2 as a cerebroprotectant in a tmcao stroke model in mice - project summary/abstract stroke affects more than 795,000 patients per year in the us, kills approximately 140,000 and is the single largest cause of expense for long-term medical care in the us. About 87% of strokes are ischemic, 40% of | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 2, 2021 | $478,050 |
Questions people ask
How much federal grant money does Nuvox Pharma, L.L.C. get?
$4.0 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Nuvox Pharma, L.L.C. the most?
The Department of Health and Human Services, with $3.1 million in 4 awards. The Department of Defense follow.
What is Nuvox Pharma, L.L.C.'s largest federal grant?
$1.5 million under Cancer Detection and Diagnosis Research, with its first action in the period on September 1, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Nuvox Pharma, L.L.C.?
Its largest are Cancer Detection and Diagnosis Research, Extramural Research Programs in the Neurosciences and Neurological Disorders and Military Medical Research and Development.
Other grant recipients in Tucson
- University of Arizona
- Association of Universities for Research in Astronomy, Inc.
- City of Tucson
- Tucson Airport Authority Inc
- Child-Parent Centers, Inc.
- Visionquest National LTD
- SOUTH32 Hermosa Inc
- Pascua Yaqui Tribe
Largest federal grant recipients in Arizona · Federal grants in Arizona